investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Mechanisms of autoinhibition and activation of the Abl kinase

Charalampos Kalodimos

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

Charalampos Kalodimos

Rutgers University

New Brunswick, United States

Related projects

Genoveffa Franchini

T-Cell Transformation by Oncoviruses

Leukaemia

Pathology Hematology and hematologic malignancies

Thomas Waldmann

IL-2/IL-15 Cytokine Receptor: Implications for Cancer Therapy and Vaccine Design

Leukaemia

Pathology Hematology and hematologic malignancies

Anthony G Letai

Probing mitochondria and personalizing leukemia therapy with BH3 profiling

Leukaemia

Richard A Flavell

Understanding Hemotopoietic Neoplasias using Humanized Mice

Leukaemia

Pathology Hematology and hematologic malignancies

Guy S Salvesen

IAP Family Proteins and Cancer

Leukaemia

Pathology Hematology and hematologic malignancies

Ross L Levine

Role of TET2 mutations in malignant transformation and acute myeloid leukemia

Leukaemia

Julia Kubanek

Ecological Leads for Drug Discovery from Marine Organisms

Leukaemia

Derrick J. Rossi

Reprogramming committed blood cells to a hematopoietic stem cell fate

Leukaemia

Hematology and hematologic malignancies

Dongsu Park

Role of osteogenic stem cells in bone regeneration and repair in vivo

Leukaemia